Rossari Biotech share news and announcements
NSE: ROSSARIBSE: 543213Chemicals & PetrochemicalsSmall Cap
Last close ₹414.70down ₹12.60 (2.95%)BSE ₹414.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹427.30.
52-week range of traded prices to 23 Oct 2026
₹375.00Low, 30 Mar 2026₹663.00High, 28 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,297 Cr1,009th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 15.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 1.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,81,48259.5% delivered
Rossari Biotech disputes and clarifications
10 filed, newest first.
Jun 2026
Jan 2026
Feb 2025
Jan 2025
31 Jan · Legal
Jun 2023
6 Jun · Legal
The exchange asked on 5 Jun 2023
Apr 2023
10 Apr · Legal
The exchange asked on 10 Apr 2023
Dec 2022
28 Dec · Legal
The exchange asked on 28 Dec 2022
Mar 2021
22 Mar · Legal
The exchange asked on 18 Mar 2021
Feb 2021
22 Feb · Legal
The exchange asked on 19 Feb 2021